METHODS OF TREATING NON-SMALL CELL LUNG CANCER WITH ANTI-PD-1-ANTIBODIES
Application
US20260083839A1
Kind: A1
Mar 26, 2026
Inventors
Martin HUBER, Niranjan YANAMANDRA, Allene DIAZ, Mary Lynne HEDLEY, Julie Ann KRUEGER, Timothy R. CROSSMAN, Hesham A. ABDULLAH
Abstract
The disclosure provides a method of treating non-small cell lung cancer (NSCLC) in a patient previously treated with an immune checkpoint inhibitor by the administration of dostarlimab or a biosimilar thereof.
CPC Classifications
A61K 39/3955
A61K 31/282
A61K 31/519
A61K 33/243
A61P 35/00
C07K 16/2818
A61K 2039/505
A61K 2039/54
A61K 2039/545
Filing Date
2023-09-22
Application No.
19113681